Aflojamiento protésico de cadera: Análisis de un caso complicado

Víctor M. Ilizaliturri S; Othón Hernández T; Fernando S. Valero G; Pedro A. Chaidez R; Jose M. Aguilera Z; Leticia del Carmen Baena

2004, Número 2

<< Anterior Siguiente >>

Rev Fac Med UNAM 2004; 47 (2)

Aflojamiento protésico de cadera: Análisis de un caso complicado

Ilizaliturri SVM, Hernández TO, Valero GFS, Chaidez RPA, Aguilera ZJM, Baena LC

Texto completo

Cómo citar este artículo

Idioma: Español
Referencias bibliográficas: 13
Paginas: 76-81
Archivo PDF: 134.00 Kb.

FRAGMENTO

Resumen de la historia clínica

Masculino de 56 años de edad originario de la ciudad de Guadalajara, Jalisco, radicando actualmente en el Distrito Federal, casado, nivel socioeconómico medio, comerciante; tabaquismo positivo de 5 cigarrillos al día, alcoholismo positivo sin llegar a la embriaguez, hábitos higiénicos y dietéticos buenos, quirúrgicos positivos en 1990 consistentes en cirugía de columna y tobillo derecho sin especificar tipo; transfusionales positivos en dichas cirugías.

REFERENCIAS (EN ESTE ARTÍCULO)

Dorr LD, Wolf AW, Chandler R, Conato JP. Classification and treatment of dislocations of total hip arthroplasty. Clin Orthop 1983; 173: 151-158.
2. DeWal H, Su E, DiCesare PE. Instability following total hip arthroplasty. Am J Orthop 2003; 32: 377-82.
3. Eingartner C, Volkmann R, Winter E, Maurer F, Sauer G, Weller S, Weise K. Results of an uncemented straight femoral shaft prosthesis after 9 years of follow-up. J Arthroplasty. 2000; 15: 440-447.
4. Mallory TH, Head WC, Lombardi AV Jr, Emerson RH Jr, Eberle RW, Mitchell MB. Clinical and radiographic outcome of a cementless, titanium, plasma spray-coated total hip arthroplasty femoral component. Justification for continuance of use. J Arthroplasty 1996; 11(6): 653-60.
5. Salvati EA, Gonzalez DVA, Masri BA, Duncan CP. The infected total hip arthroplasty. Instr Course Lect 2003; 52: 223-45.
6. Mitchell PA, Masri BA, Garbuz DS, Greidanus NV, Duncan CP. Cementless revision for infection following total hip arthroplasty. Instr Course Lect. 2003; 52: 323-30.
7. Saeed S, Revell PA. Production and distribution of interleukin 15 and its receptors (IL-15R alpha and IL-R2 beta) in the implant interface tissues obtained during revision of failed total joint replacement. Int J Exp Pathol 2001; 82: 201-9.
8. Goodman SB, P Huie Y, Song D, Schurman W, Maloney S, Woolson RS. Cellular profile and cytokine production at prosthetic interfaces. J Bone Joint Surg 1998; 80-B: 531-39.
9. Vidovszky TJ, Cabanela ME, Rock MG, Berry JD, Morrey BF, Bolander ME. Histologic and Biochemical differences between Osteolitic and Nonosteolytic membranes around femoral components of an uncemented total hip arthroplasty. J Artroplasty 1998; 13: 320-30.
10. Neale SD, Athanasou NA. Cytokine receptor profile of arthroplasty macrophages, foreign body giant cells and mature osteclasts. Acta Orthop Scand 1999; 70: 452-58.
11. Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg 2003; 85-A(1): 27-32.
12. Nourbash PS, Paprosky WG. Cementless femoral design concerns. Rationale for extensive porous coating. Clin Orthop 1998; 355: 189-99.
13. Ebramzadeh E, Normand PL, Sangiorgio SN, Llinas A, Gruen TA, McKellop HA, Sarmiento A. Long-term radiographic changes in cemented total hip arthroplasty with six designs of femoral components. Biomaterials 2003; 24: 3351-63.